[1] AMSB Chem Consulting, Brisbane, Qld, Australia
[2] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia
[3] WHO, Antimicrobial Resistance Div, Geneva, Switzerland
[4] F2G Ltd, Eccles, Cheshire, England
[5] Univ Texas Hlth Sci Ctr, EMcGovern Med Sch, Houston, TX USA
[6] GARDP, Scient Advisory Comm, Geneva, Switzerland
[7] Natl Biodefense Sci Board, Hlth & Human Serv, Washington, DC USA
[8] Houston Methodist Res Inst, Ctr Infect Dis Res, Houston, TX USA
[9] UTHealth Sch Publ Hlth, Ctr Infect Dis, Houston, TX USA
[10] Infect Dis Inst, Rambam Hlth Care Campus, Haifa, Israel
[11] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel
[12] Univ Oxford, Clin Res Unitgrid 412433 3, Ho Chi Minh City, Vietnam
[13] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England
[14] Chem Biol Ventures Ltd, Abingdon, Oxon, England
[15] Boston Univ, OCARB X, Boston, MA USA
[16] Univ Montpellier, Inst Rech Dev, INSERM, Montpellier, France
[17] TB Alliance, New York, NY USA
[18] LL Silver Consulting, Springfield, NJ USA
[19] Natl Ctr Global Hlth & Med, Shinjuku City, Tokyo, Japan
[20] Smolensk State Med Univ, TInstitute Antimicrobial Chemotherapy, Smolensk, Russia
[21] Natl Ctr Infect Prevent, Bern, Switzerland
[22] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland
[23] WHO Collaborating Ctr Patient Safety, Fac Med, Geneva, Switzerland